Haemonetics SVP reports tax-withheld 313 shares

Haemonetics Corp senior vice president of human resources Laurie A. Miller reported a small share disposition related to taxes.

Rhea-AI Filing Summary

Haemonetics Corp senior vice president of human resources Laurie A. Miller reported a small share disposition related to taxes. On the vesting of previously granted restricted stock units, 313 shares of common stock were withheld at a price of $71.28 per share to cover tax obligations. After this tax-withholding event, Miller directly holds 40,987 shares of Haemonetics common stock, which includes unvested restricted stock units.

Insider Trade Summary

Exercise Price or Tax Liability: 313 shares

Exercise Price or Tax Liability 1 txn

Insider Miller Laurie A.

Role SVP, Human Resources

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Common Stock	313	$71.28	$22K

Holdings After Transaction: Common Stock — 40,987 shares (Direct)

Footnotes (2)

1. F1. Represents shares withheld for tax obligations in connection with the vesting of certain restricted stock units ("RSUs") previously reported in Table I.
2. F2. This number includes unvested RSUs previously reported.

Key Figures

Tax-withheld shares: 313 shares Per-share value: $71.28 per share Shares held after: 40,987 shares +1 more

4 metrics

Tax-withheld shares 313 shares Withheld for tax obligations on RSU vesting

Per-share value $71.28 per share Value used for tax-withholding disposition

Shares held after 40,987 shares Direct holdings after tax withholding, including unvested RSUs

Tax-withholding transactions 1 transaction Single F-code tax-withholding disposition reported

Key Terms

restricted stock units ("RSUs"), tax-withholding disposition, Payment of exercise price or tax liability by delivering securities, unvested RSUs

4 terms

restricted stock units ("RSUs") financial

"Represents shares withheld for tax obligations in connection with the vesting of certain restricted stock units ("RSUs") previously reported"

Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.

tax-withholding disposition financial

"transaction_action: "tax-withholding disposition" for the 313 common shares"

A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.

Payment of exercise price or tax liability by delivering securities financial

"transaction_code_description: "Payment of exercise price or tax liability by delivering securities""

unvested RSUs financial

"This number includes unvested RSUs previously reported."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Haemonetics (HAE) report for Laurie A. Miller?

Laurie A. Miller reported a tax-related share disposition where 313 Haemonetics common shares were withheld. The shares covered tax obligations upon vesting of previously granted restricted stock units, rather than representing an open-market sale.

How many Haemonetics (HAE) shares were withheld for taxes in this Form 4?

A total of 313 common shares of Haemonetics were withheld to satisfy Miller’s tax obligations. This tax-withholding occurred in connection with the vesting of restricted stock units, as described in the Form 4 footnotes.

At what price were the withheld Haemonetics (HAE) shares valued?

The 313 withheld shares were valued at $71.28 per share. This price is used in the Form 4 to report the value of shares applied toward Miller’s tax liability on the vesting restricted stock units.

How many Haemonetics (HAE) shares does Laurie A. Miller hold after this transaction?

Following the tax-withholding disposition, Miller directly holds 40,987 Haemonetics common shares. This figure includes unvested restricted stock units previously reported, as noted in the Form 4 footnotes.

Was the Haemonetics (HAE) insider transaction an open-market sale?

No. The Form 4 describes a tax-withholding disposition, not an open-market sale. Shares were withheld by the company to pay tax obligations tied to the vesting of restricted stock units.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/08/2026 - 04:16 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Miller Laurie A.

(Last) (First) (Middle)

125 SUMMER STREET

(Street)

BOSTON MASSACHUSETTS 02110

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
HAEMONETICS CORP [ HAE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP, Human Resources

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/05/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/05/2026		F		313(1)	D	$71.28	40,987(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares withheld for tax obligations in connection with the vesting of certain restricted stock units ("RSUs") previously reported in Table I.

2. This number includes unvested RSUs previously reported.

	/s/ Thomas V. Powers, attorney-in-fact for Ms. Miller	06/08/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)